Duchenne Parent Project and European Reference Network for Neuromuscular Diseases can now begin leveraging their FAIR data to benefit People Living With Rare Diseases.

Veenendaal, September 1st, 2022 | Joint Press Release: The Duchenne Parent Project, ERN EURO-NMD and FAIR Data Systems S.L. are proud to announce that with other collaborators they have made an important step in solving the long-standing obstacle of how to conduct queries between rare disease FAIR data registries without exposing sensitive patient details. That is, how to leverage the value of FAIR interoperability while simultaneously protecting patient privacy. The solution is based on technology that connects Web addresses to database queries, thus limiting database exploration to only pre-approved questions. It is available in the form of a publicly accessible demonstration prototype running in the Jupyter data analytics environment

FAIR Data

FAIR stands for Findable, Accessible, Interoperable, and Reusable. The acronym is used to describe a global initiative to make data more valuable by increasing the ability of computers to find, interpret, integrate, and analyze those data autonomously. In this prototype, the computer calls the special Web address causing a specified query to be executed inside the FAIR registry’s secure space. As an output, anonymized data are given back to the computer. 

The Prototype

The prototype depends on a publicly available database of queries that were manually curated and filtered by experts in FAIR and neuromuscular diseases. FAIR makes it possible for the same query to be executed over independent resources, and thus sharing those queries leads to convergence between registries. For example, the Duchenne Parent Project (i.e. Duchenne Data Platform) and European Reference Network for all Neuromuscular Diseases (i.e. EURO-NMD), as illustrated below:

FAIR DATA

Figure explained: Privacy-preserving federation of DPP and EURO-NMD. The top and bottom layers show the customized, secure services (called “grlc”) operating in each registry’s protected space, sharing a folder of queries stored at the World Duchenne Organization’s GitHub repository. Queries will be executed, on demand, over their FAIR datasets (to the right of the diagram).  All of this is protected by a “proxy”, which further insulates the other components, and ensures only encrypted communication over the Web. Accessing the proxy retrieves, in this example, only a count of the number of patients with a given rare disease that can be aggregated in a graphical analytics environment. 

Note: Mock data were used to generate a count for EURO-NMD as the registry is still not holding data at present. 

“We have made it easy for new FAIR registries to participate in federated queries, without deep concerns about security.” Explains Peter-Bram ‘t Hoen, Professor of Bioinformatics at Radboud University Medical Center and work-package leader, FAIRification and Interoperability of the EURO-NMD EU-funded project. “For patients, they can be assured that their data are being reused, in a secure manner, by scientists, clinicians or other authenticated and authorized health professionals – which is their desire.”

Next Steps

The next steps are to increase the number and sophistication of the publicly available queries – all reviewed for security by both technical and rare disease experts – in the demonstration prototype. This will hopefully encourage other FAIR registries to use the demonstration prototype to participate in privacy-preserving scientific analyses over multiple registries. For example, the prototype could be integrated in the European Joint Programme on Rare Diseases Virtual Platform once the development of this platform is completed.

About Duchenne Parent Project (DPP)

The Duchenne Parent Project, a patient advocacy group in The Netherlands, was founded in 1994. It strives to raise awareness, accelerate research to find a cure, improve treatments, and optimise access to care for everyone with Duchenne and Becker Muscular Dystrophy. 

For more information, visit https://duchenne.nl.

About EURO-NMD 

EURO-NMD is a European Reference Network that aims to harmonise and implement best practices for clinical and diagnostic procedures for rare neuromuscular diseases across all European Union member states. 

For more information visit https://ern-euro-nmd.eu.

About FAIR Data Systems

FAIR Data Systems is a leading consultancy company in planning, building, and providing

training in FAIR-compliant data systems. For more information visit https://fairdata.systems/home/.

Acknowledgements 

Elizabeth Vroom and Mirjam Franken at DPP and the Steering Committee of EURO-NMD would like to extend their appreciation to their collaborators: FAIR Data Systems S.L. (Mark D. Wilkinson, Eduardo Quemada and Alberto Camara), EURO-NMD (Adrian Tassoni and Dagmar Jaeger), Radboud University Medical Centre (Peter-Bram ‘t Hoen and Bruna Dos Santos Vieira), Leiden University Medical Centre (Marco Roos and Rajaram Kaliyaperumal).


For any additional information, please reach out to Nawel Lalout, Project Manager FAIR Duchenne Data at [email protected].